ACSM3 and ovarian carcinoma: Here, we found that the overexpressed ACSM3 blocked the expression of Integrin β1 and p-AKT, leading to the down-regulation of cyclin D1, c-Myc, Vimentin and the up-regulation of E-cadherin in ovarian cancer cells.